Old Web
English
Sign In
Acemap
>
authorDetail
>
Jason C. Martin
Jason C. Martin
Merck & Co.
Immunogenicity
Medicine
Placebo
Dengue vaccine
Randomized controlled trial
2
Papers
18
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older.
2021
Human Vaccines & Immunotherapeutics
Ulrike K. Buchwald
Charles P. Andrews
John Ervin
James T. Peterson
Gretchen M. Tamms
David Krupa
Patrick Ajiboye
Lucy Roalfe
Andrea Likos Krick
Tina M. Sterling
Meihua Wang
Jason C. Martin
Jon E. Stek
Melvin A. Kohn
Temitope Folaranmi
Chitrananda Abeygunawardana
Jonathan Hartzel
Luwy Musey
Show All
Source
Cite
Save
Citations (1)
Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-Naïve adults
2018
Human Vaccines & Immunotherapeutics
Susan B. Manoff
Sausser M
Falk Russell A
Jason C. Martin
David Radley
Donna Hyatt
Christine C. Roberts
Lickliter J
Krishnarajah J
Andrew J. Bett
Sheri A. Dubey
Finn T
Coller Ba
Show All
Source
Cite
Save
Citations (17)
1
map